Institution-Grade Tools, Priced for Individual Investors.
Receive trading alerts directly to your inbox. Try Barchart Plus or Barchart Premier for free today.
/Tesla%20Inc%20logo%20by-%20baileystock%20via%20iStock.jpg)
/Meta%20Platforms%20by%20Primakov%20via%20Shutterstock.jpg)
/A%20concept%20image%20of%20a%20self-driving%20car%20image%20by%20Gorodenkoff%20via%20Shutterstock.jpg)
/A%20Palantir%20office%20building%20in%20Tokyo_%20Image%20by%20Hiroshi-Mori-Stock%20via%20Shutterstock_.jpg)
/AI%20(artificial%20intelligence)/Artificial%20intelligence%20and%20machine%20learning%20concept%20-%20by%20amgun%20via%20iStock.jpg)
Nebius stock rallies as Goldman Sachs issues a bullish note in its favor. Analyst Alex Duval expects NBIS shares to hit $68 over the next 12 months.
While DGX stock has been hammered in the market recently, the smart money may be sensing a bounce-back opportunity.
This article outlines a three-part plan by a top analyst to stabilize Tesla stock amid mounting investor concerns over Elon Musk’s political distractions.
Alibaba is off its May $134 peak as Trump's tariff pressure is on again. Analysts have cut EPS forecasts and price targets. So, is BABA a buy? Maybe, but one attractive income play here is to short deep...
Nvidia hit record highs last week, and the company’s market cap surpassed $4 trillion. The stock has room to run higher if Nvidia can get concessions on chip exports to China.
/GE%20Aerospace%20turbine%20engine-by%20hapabapa%20via%20iStock.jpg)
As the company heads into its second-quarter earnings report, there’s a growing confidence among analysts, who are bullish about GE’s prospects.
/Netflix%20on%20tv%20with%20remote%20by%20freestocks%20via%20Unsplash.jpg)
After a solid start to the year, analysts are forecasting even stronger performance for Q2, with both revenue and earnings projected to accelerate compared to the first quarter.
September U.S. T-bond futures present a selling opportunity on more price weakness.
Tapestry (TPR) shows exceptional technical momentum and shares set a new all-time high on July 14. TPR has a 100% “Buy” signal via Barchart. The stock has gained 127% over the past year and trades...
As ProKidney hits a fresh 52-week high, can it sustain momentum through late-stage trials, or should investors stay cautious amid the market’s mixed view?
